# US 2006/0234298 A1 · Systems and methods for rapidly changing the solution environment around sensors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0234298 A1
- Document ID: US20060234298A1
- Status: Published application
- Kind: A1
- Application number: 11/031,513
- Filed: 2005-01-06
- Published: 2006-10-19
- Earliest claimed: 2002-02-12
- Assignees: Cellectricon AB
- Inventors: Daniel Chiu; Owe Orwar; Kent Jardemark; Mattias Karlsson; Jessica Olofsson; Johan Pihl; Jon Sinclair
- Web page: https://patentgrep.com/patent/US20060234298A1

## CPC

- B01L 3/502715: {characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces}
- B01L 3/5025: {for parallel transport of multiple samples}
- B01L 3/502776: {specially adapted for focusing or laminating flows}
- B01L 3/5085: {for multiple samples, e.g. microtitration plates}
- G01N 29/022: {Fluid sensors based on microsensors, e.g. quartz crystal-microbalance [QCM], surface acoustic wave [SAW] devices, tuning forks, cantilevers, flexural plate wave [FPW] devices (microdevices per se B81B)}
- G01N 33/48728: {Investigating individual cells, e.g. by patch clamp, voltage clamp (investigating individual particles in general G01N15/10)}
- G01N 33/543: with an insoluble carrier for immobilising immunochemicals
- G01N 33/554: the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
- G01N 33/56966: {Animal cells}
- B01L 3/502738: {characterised by integrated valves (throttle valves in microfluidic sample containers B01L3/502746)}
- B01L 3/502746: {characterised by the means for controlling flow resistance, e.g. flow controllers, baffles or throttle valves}
- B01L 2200/0636: Focussing flows, e.g. to laminate flows
- B01L 2300/0645: Electrodes
- B01L 2300/0816: Cards, e.g. flat sample carriers usually with flow in two horizontal directions
- B01L 2300/0829: Multi-well plates; Microtitration plates
- B01L 2300/0861: Configuration of multiple channels and/or chambers in a single devices
- B01L 2300/0867: Multiple inlets and one sample wells, e.g. mixing, dilution
- B01L 2300/0877: Flow chambers
- B01L 2400/0418: electro-osmotic flow [EOF]
- B01L 2400/0421: electrophoretic flow
- G01N 2291/02836: Flow rate, liquid level
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention provides microfluidic systems for altering the solution environment around a nanoscopic or microscopic object, such as a sensor, and methods for using the same. The invention also provides a system and methods for modulating, controlling, preparing, and studying receptors.

## Claims

### Claim 1

A method for modulating, controlling, preparing, or studying receptors, comprising:
a) providing a substrate, the substrate comprising:
a chamber comprising a cell-based biosensor, the cell-based biosensor comprising a receptor which is activated by an agonist or a receptor which is inactivated by an antagonist; and
a plurality of delivery channels delivering one or more of sample, agonist, antagonist, each channel comprising an outlet for delivering a substantially separate aqueous stream into the chamber; and
(b) sequentially exposing the biosensor to a fluid stream from two or more outlets.

### Claim 2 (depends on 1)

The method of claim 1, wherein the chamber comprises a buffer, at least one agonist, at least one antagonist, at least one sample, or a combination thereof.

### Claim 3 (depends on 1)

The method of claim 1, wherein the exposing is selectively exposing the biosensor to a selected concentration of sample.

### Claim 4 (depends on 1)

The method of claim 1, wherein the exposing is selectively for a selected time.

### Claim 5 (depends on 1)

The method of claim 1, further comprising providing to the channels one or more buffers.

### Claim 6 (depends on 1)

The method of claim 1, fuirther comprising exposing the biosensor to the one or more buffers.

### Claim 7 (depends on 1)

The method of claim 1, wherein the exposing the biosensor to one or more buffers is interspersed between the exposing to one or more samples.

### Claim 8 (depends on 1)

The method of claim 1, wherein the exposing to one or more buffers is a wash period.

### Claim 9 (depends on 1)

The method of claim 1, wherein the exposing to one or more buffers is a rest period.

### Claim 10 (depends on 1)

The method of claim 1, wherein the exposing to one or more buffers is a wash and a rest period.

### Claim 11 (depends on 1)

The method of claim 1, wherein a rest period in buffer is between a series of sample exposures and interdigitated by one or more wash periods in buffer.

### Claim 12 (depends on 1)

The method of claim 1, comprising selectively exposing the biosensor to streams of buffer and sample.

### Claim 13 (depends on 1)

The method of claim 1, comprising selectively exposing the biosensor to alternating streams of buffer and sample.

### Claim 14 (depends on 1)

The method of claim 1, wherein the receptors are exposed to ligand solutions in order of increasing concentrations

### Claim 15 (depends on 1)

The method of claim 1, wherein the receptors are exposed to ligand solutions in order of decreasing concentrations

### Claim 16 (depends on 1)

The method of claim 1, wherein the receptors are exposed to ligand solutions in order of increasing concentrations followed by exposure to ligand solutions in order of decreasing concentrations.

### Claim 17 (depends on 1)

The method of claim 1, wherein the receptors are exposed to ligand solutions in order of decreasing concentrations followed by exposure to ligand solutions in order of increasing concentrations

### Claim 18 (depends on 16, 17)

The method of any of claims 16 or 17, wherein the receptors are exposed to washing solution after ascending or descending exposures of modulator.

### Claim 19 (depends on 1)

The method of claim 1, wherein the agent is a candidate drug; a known drug; a suspected carcinogen; a known carcinogen; a candidate toxic agent, a known toxic agent; and an agent that acts directly or indirectly on ion channels.

### Claim 20 (depends on 1)

The method of claim 1, wherein the method for studying is a method for studying the memory properties of a receptor.

### Claim 21 (depends on 1)

The method of claim 1, wherein the memory functions are short-term, medium-term, or long-term memory functions.

### Claim 22 (depends on 1)

The method of claim 1, wherein the effects of a drug on memory properties of a biosensor are studied.

### Claim 23 (depends on 1)

The method of claim 1, wherein the exposing further comprises producing pressure drops across one or more channels.

### Claim 24 (depends on 1)

The method of claim 1, wherein the same sample is provided to a plurality of channels.

### Claim 25 (depends on 24)

The method of claim 24, wherein different concentrations of the sample are provided to the plurality of channels.

### Claim 26 (depends on 25)

The method of claim 25, further comprising generating a dose-response curve for the sample.

### Claim 27 (depends on 26)

The method of claim 26, wherein the cell-based biosensor comprises a patch-clamped cell or patch-clamped cell membrane fraction.

### Claim 28 (depends on 27)

The method of claim 27, wherein the patch-clamped cell is positioned relative to the outlets using a patch clamp pipette coupled or connected to a positioner.

### Claim 29 (depends on 26)

The method of claim 26, wherein the sample is an agonist.

### Claim 30 (depends on 26)

The method of claim 26, wherein the sample is an antagonist.

### Claim 31 (depends on 26)

The method of claim 26, wherein the sample is a candidate molecule.

### Claim 32 (depends on 1)

The method of claim 1, wherein the cell-based biosensor comprises an ion-channel.

### Claim 33 (depends on 1)

The method of claim 1, wherein the receptor comprises a G-protein coupled receptor.

### Claim 34 (depends on 1)

The method of claim 1, wherein the cell-based biosensor comprises a recombinantly expressed receptor.

### Claim 35 (depends on 34)

The method of claim 34, wherein the recombinantly expressed receptor is an orphan receptor.

### Claim 36 (depends on 26)

The method of claim 26, wherein the response is determined by measuring cell surface area.

### Claim 37 (depends on 26)

The method of claim 26, wherein the response is determined by measuring an electrical property of the cell-based biosensor.

### Claim 38 (depends on 26)

The method of claim 26, wherein the sample is a modulator of neurotransmitter release.

### Claim 39 (depends on 26)

The method of claim 26, wherein the response is determined by measuring ion-channel permeability properties.

### Claim 40

A method of preparing a receptor in a discrete kinetic state, comprising:
sequentially exposing a cell-based biosensor to two or more concentrations of modulator, and
alternating resting and washing periods between exposures to modulator, wherein the sequential exposure arrests the biosensor in a pre-determined kinetic state.

### Claim 41 (depends on 40)

A method of claim 40, wherein the sequentially exposing ranges from between about 1 ms to about 180 minutes.

### Claim 42 (depends on 40)

The method of claim 40, wherein the sequentially exposing ranges from between about 1 ms to about 60 minutes.

### Claim 43 (depends on 40)

The method of claim 40, wherein the wherein the sequentially exposing ranges from between about 1 ms to tens of minutes.

### Claim 44 (depends on 40)

The method of claim 40, wherein the sequentially exposing ranges from between about 1 ms to the death of the cell.

### Claim 45 (depends on 40)

The method of claim 40, wherein the resting ranges from between about 1 ms to about 180 minutes.

### Claim 46 (depends on 40)

The method of claim 40, wherein the resting ranges from between about 1 ms to about 60 minutes.

### Claim 47 (depends on 40)

The method of claim 40, wherein the resting ranges from between about 1 ms to tens of minutes.

### Claim 48 (depends on 40)

The method of claim 40, wherein the resting ranges from between about 1 ms to the death of the cell.

### Claim 49 (depends on 40)

The method of claim 40, wherein the washing periods range from between about 1 ms to about 180 minutes.

### Claim 50 (depends on 40)

The method of claim 40, wherein the washing periods range from between about 1 ms to about 60 minutes.

### Claim 51 (depends on 40)

The method of claim 40, wherein the washing periods range from between about 1 ms to tens of minutes.

### Claim 52 (depends on 40)

The method of claim 40, wherein the washing periods range from between about 1 ms to the death of the cell.

### Claim 53 (depends on 40)

A method of claim 40, further comprising determining the molecular memory of a biosensor.

### Claim 54 (depends on 40)

A method of claim 40, wherein the molecular memory is determined by measuring a dose response of the modulator.

### Claim 55 (depends on 40)

A method of claim 40, further comprising providing a system comprising:
a substrate for changing a solution environment around a sensor, the substrate comprising a plurality of channels, each channel comprising an outlet; and
a scanning mechanism for selectively exposing a sensor to a fluid stream from an outlet.

### Claim 56 (depends on 40)

A method of claim 40, wherein increasing concentrations of modulator are exposed to the biosensor.

### Claim 57 (depends on 40)

A method of claim 40, wherein decreasing concentrations of modulator are exposed to the biosensor.

### Claim 58 (depends on 40)

A method of claim 40, wherein the modulator is a candidate drug; a known drug; a suspected carcinogen; a known carcinogen; a candidate toxic agent, a known toxic agent; and an agent that acts directly or indirectly on ion channels.
